Purchases and Sales Made in Q2 2024 in Capricor Therapeutics, Inc. (CAPR)
This table provides information about the institutional ownership of Capricor Therapeutics, Inc. (CAPR) during Q2 2024. The information is specifically focused on institutions that hold shares of CAPRICOR THERAPEUTICS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
SELL
|
- |
-67.1K- 85.63% |
$311K - $476K
|
11.3K
$204K
|
|
|
Aug 14, 2024
Q2 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-74.3K- 80.23% |
$344K - $527K
|
18.3K
$331K
|
|
|
Aug 12, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-80.3K- 88.12% |
$372K - $569K
|
10.8K
$196K
|
|
|
Aug 13, 2024
Q2 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-130K- 61.21% |
$604K - $925K
|
82.7K
$1.5M
|
|
|
Aug 15, 2024
Q2 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-276K- 87.2% |
$1.28M - $1.96M
|
40.5K
$733K
|